Successful treatment of enterocutaneous fistula in a premature newborn by using octreotide

Ilker Büyükyavuz; Ibrahim Karnak; Sule Yiğit; F Cahit Tanyel

doi:10.24953/turkjped.2004.2821

Case Report

Turk J Pediatr 2004; 46(3): 289-291.

PDF

Successful treatment of enterocutaneous fistula in a premature newborn by using octreotide

Authors

Ilker Büyükyavuz

Ibrahim Karnak

Sule Yiğit

F Cahit Tanyel

Affiliations

Turk J Pediatr 2004; 46(3): 289-291. DOI: 10.24953/turkjped.2004.2821

Published: July 25, 2004

Abstract

A premature newborn with an enterocutaneous fistula after repair of duodenal perforation is reported to emphasize the therapeutic effect of octreotide in persistent fistula even in a very small infant. Our report showed that use of octreotide was safe even in premature infants with intestinal fistula. Close monitorization of biochemical and blood parameters is needed in patients treated with octreotide.

Copyright and license

Copyright © 2004 The Author(s). This is an open access article distributed under the Creative Commons Attribution License (CC BY), which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.

How to cite

Büyükyavuz I, Karnak I, Yiğit S, Tanyel FC. Successful treatment of enterocutaneous fistula in a premature newborn by using octreotide. Turk J Pediatr 2004; 46: 289-291. https://doi.org/10.24953/turkjped.2004.2821